Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Suskind, Dana L.
Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction.
Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology. 1999 Dec; 117(6):1271-7.
View in:
PubMed
subject areas
Adult
Anti-Inflammatory Agents, Non-Steroidal
Crohn Disease
Electromyography
Female
Humans
Male
Middle Aged
Thalidomide
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer
Russell D. Cohen